ID   MTT-95
AC   CVCL_B432
DR   Cosmic; 1012101
DR   Cosmic; 2306223
DR   Wikidata; Q54907026
RX   PubMed=10358725;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=10358725; DOI=10.18926/AMO/31624;
RA   Mizobuchi, Noriko
RA   Takahashi, Isao
RA   Yorimitsu, Seiichi
RA   Horimi, Tadashi
RA   Hamada, Kyoko
RA   Matsuoka, Misuzu
RA   Sonobe, Hiroshi
RA   Hiroi, Makoto
RA   Kubonishi, Ichiro
RT   "Establishment of a new cell line (MTT-95) showing basophilic
RT   differentiation from the bone marrow of a patient with acute
RT   myelogenous leukemia (M7).";
RL   Acta Med. Okayama 53:95-98(1999).
//
RX   PubMed=16408098; DOI=10.1038/sj.leu.2404081;
RA   Quentmeier, Hilmar
RA   MacLeod, Roderick A.F.
RA   Zaborski, Margarete
RA   Drexler, Hans Gunther
RT   "JAK2 V617F tyrosine kinase mutation in cell lines derived from
RT   myeloproliferative disorders.";
RL   Leukemia 20:471-476(2006).
//